Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07145372Not ApplicableCompleted

Diaphragm Relaxation Techniques, Diaphragmatic Breathing Exercises for Migraine Patients

Role: lead

NCT07127549Completed

Core Muscle Strength, Endurance, and Balance in Women With Urinary Incontinence

Role: lead

NCT06069908Not ApplicableCompleted

Transcutaneous Auricular Vagus Nerve Stimulation in Upper Extremity Lymphedema

Role: lead

NCT05718713Unknown

Respiration in Chronic Low Back Pain

Role: lead

All 4 trials loaded